Emergent BioSolutions | GÆLD

Debt Lave om Dato
Acadia Pharmaceuticals USD 0 0 2022-06
ALKERMES USD 291.37M 635K 2023-09
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amarin USD 0 0 2022-06
ANI Pharmaceuticals USD 285.67M 213K 2023-12
BioMarin Pharmaceutical USD 1.09B 988K 2023-12
Exact Sciences USD 2.38B 8.06M 2023-12
Exelixis USD 0 0 2022-03
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
Ironwood Pharmaceuticals USD 697.87M 24.59M 2023-12
Lonza CHF 2.91B 678M 2023-06
Merck USD 34.86B 2.05B 2023-09
Moderna USD 575M 150M 2023-12
Myriad Genetics USD 38.5M 0 2023-12
Neurocrine Biosciences USD 169.9M 200K 2023-09
Pacira USD 522.44M 2.14M 2023-12
Pfizer USD 63.6B 1.74B 2023-09
PTC Therapeutics USD 2.12B 762.21M 2023-12
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
United Therapeutics USD 700M 100M 2023-12



Emergent BioSolutions GÆLD - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.